Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes
J. Claiborne Stephens(National Cancer Institute), Michael Dean(National Cancer Institute), David Goldstein(New South Wales Department of Health), David Reich(Broad Institute), Paolo Gasparini(Brigham and Women's Hospital), Mary Carrington(Ragon Institute of MGH, MIT and Harvard), Rando Allikmets(Structural Genomics Consortium), George Nasioulas(Athens Medical Center), Cheryl A. Winkler(Frederick National Laboratory for Cancer Research), Hiljar Sibul(Boston Children's Hospital), Emmanouel Kanavakis, Xavier Estivill(Barcelona Biomedical Research Park), David L. Duffy(The University of Queensland), Michael Aseev(Russian Academy of Sciences), Francesco S. di Giovine(University of Sheffield), Michael Malasky(Science Applications International Corporation (United States)), Marios Kambouris(Qatar Airways (Qatar)), David Goldman(Unknown), Harry Ostrer(Albert Einstein College of Medicine), Bernard Gerrard(National Cancer Institute), Damjan Glavač(University of Ljubljana), Maria Tzetis, Michael W. Smith(National Cancer Institute), Gordon W. Duff(University of Canberra), Stephen J. O’Brien(Nova Southeastern University), Carole Oddoux(University Medical Center), Hyoung Doo Shin(Sogang University), В. С. Баранов(University of Pittsburgh), Susanne Morlot(Medizinische Hochschule Hannover), Lynn M. Schriml(Center for Genomic Science), Gavin Huttley(Science Applications International Corporation (United States)), María Dolores Burguete Ramos(Duran i Reynals Hospital), Mireille Claustres(Université de Montpellier), Andres Metspalu(Boston Children's Hospital), Jörg Schmidtke(Medizinische Hochschule Hannover), David Chandler(Edith Cowan University), Luba Kalaydjieva(Edith Cowan University), Matthew Hanson(Center for Genomic Science)
Cited by 525
Related Papers
QIIME allows analysis of high-throughput community sequencing data
|Nature Methods|2010|36k
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.2k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
A framework for human microbiome research
|Nature|2012|2.8k